Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Xenon Pharmaceuticals Inc.(XENE) | 1,161,237 | 1,328,175 | +166,938 | $45.52M | $44.56M | 6.98% | -$960.2K |
| Apogee Therapeutics Inc | 931,728 | 1,151,199 | +219,471 | $42.21M | $43.01M | 6.73% | +$801.5K |
| Verona Pharma PlcADS | 660,000 | 615,000 | -45,000 | $30.65M | $39.05M | 6.11% | +$8.40M |
| Arcellx Inc COMMON STOCK | 425,000 | 530,000 | +105,000 | $32.59M | $34.77M | 5.44% | +$2.17M |
| Alkermes plcSHS(ALKS) | 1,100,000 | 1,000,000 | -100,000 | $31.64M | $33.02M | 5.17% | +$1.38M |
| Nuvalent Inc | 285,000 | 460,000 | +175,000 | $22.31M | $32.62M | 5.11% | +$10.31M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 82,500 | 80,000 | -2,500 | $25.46M | $26.50M | 4.15% | +$1.04M |
| Centessa Pharmaceuticals PlcADS | 1,095,924 | 1,546,662 | +450,738 | $18.36M | $22.24M | 3.48% | +$3.88M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,400,000 | 1,400,000 | 0 | $30.86M | $21.52M | 3.37% | -$9.34M |
| Protagonist Therapeutics Inc | 130,000 | 400,000 | +270,000 | $5.02M | $19.34M | 3.03% | +$14.33M |
| Travere Therapeutics, Inc.(TVTX) | 200,000 | 1,070,000 | +870,000 | $3.48M | $19.17M | 3.00% | +$15.69M |
| Mineralys Therapeutics, Inc.(MLYS) | 350,000 | 1,100,000 | +750,000 | $4.31M | $17.47M | 2.73% | +$13.16M |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 0 | 30,000 | +30,000 | $0 | $16.78M | 2.63% | +$16.78M |
| Wave Life Sciences, Inc.SHS(WVE) | 1,500,000 | 1,825,000 | +325,000 | $18.55M | $14.75M | 2.31% | -$3.81M |
| Omeros CorpNOTE 5 250 2 1 | 0 | 0 | 0 | $14.61M | $14.28M | 2.23% | -$339.7K |
| Merus N V | 389,241 | 321,962 | -67,279 | $16.37M | $13.55M | 2.12% | -$2.82M |
| Axsome Therapeutics, Inc.(AXSM) | 75,000 | 100,000 | +25,000 | $6.35M | $11.66M | 1.83% | +$5.32M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $11.87M | $11.61M | 1.82% | -$256.3K |
| Establishment Labs Holdings Inc.(ESTA) | 279,445 | 280,000 | +555 | $12.87M | $11.43M | 1.79% | -$1.45M |
| Insmed Incorporated(INSM) | 50,000 | 140,000 | +90,000 | $3.45M | $10.68M | 1.67% | +$7.23M |
| BridgeBio Pharma, Inc.(BBIO) | 200,000 | 300,000 | +100,000 | $5.49M | $10.37M | 1.62% | +$4.88M |
| Nurix Therapeutics, Inc.(NRIX) | 940,083 | 810,669 | -129,414 | $17.71M | $9.63M | 1.51% | -$8.08M |
| Vera Therapeutics, Inc.CL A(VERA) | 425,000 | 355,143 | -69,857 | $17.97M | $8.53M | 1.34% | -$9.44M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 1,250,000 | +1,250,000 | $0 | $7.86M | 1.23% | +$7.86M |
| Spyre Therapeutics, Inc.(SYRE) | 824,328 | 481,678 | -342,650 | $19.19M | $7.77M | 1.22% | -$11.42M |
| Immunovant, Inc.(IMVT) | 100,000 | 430,000 | +330,000 | $2.48M | $7.35M | 1.15% | +$4.87M |
| Travere Therapeutics, Inc.NOTE 2 250 3 0(TVTX) | 0 | 0 | 0 | $5.74M | $6.99M | 1.09% | +$1.25M |
| Newamsterdam Pharma Company ORDINARY SHARES | 425,000 | 325,000 | -100,000 | $10.92M | $6.65M | 1.04% | -$4.27M |
| Oruka Therapeutics, Inc.(ORKA) | 368,698 | 545,362 | +176,664 | $7.15M | $5.60M | 0.88% | -$1.55M |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 50,000 | +50,000 | $0 | $5.53M | 0.87% | +$5.53M |
| Avalo Therapeutics, Inc.(AVTX) | 550,765 | 657,154 | +106,389 | $4.09M | $5.26M | 0.82% | +$1.17M |
| Viridian Therapeutics, Inc.(VRDN) | 159,614 | 390,000 | +230,386 | $3.06M | $5.26M | 0.82% | +$2.20M |
| Lexeo Therapeutics, Inc.(LXEO) | 0 | 1,480,881 | +1,480,881 | $0 | $5.14M | 0.80% | +$5.14M |
| Crinetics Pharmaceuticals In | 460,000 | 152,252 | -307,748 | $23.52M | $5.11M | 0.80% | -$18.41M |
| Rezolute, Inc.(RZLT) | 1,575,000 | 1,700,000 | +125,000 | $7.72M | $4.93M | 0.77% | -$2.79M |
| Perspective Therapeutics, Inc.(CATX) | 1,300,000 | 2,224,196 | +924,196 | $4.15M | $4.74M | 0.74% | +$590.5K |
| Autolus Therapeutics plcADS(AUTL) | 4,500,000 | 3,045,000 | -1,455,000 | $10.57M | $4.72M | 0.74% | -$5.86M |
| Erasca, Inc.(ERAS) | 2,499,431 | 3,341,519 | +842,088 | $6.27M | $4.58M | 0.72% | -$1.70M |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 2,825,000 | 3,284,512 | +459,512 | $7.49M | $4.37M | 0.68% | -$3.12M |
| uniQure N.V.SHS(QURE) | 0 | 400,000 | +400,000 | $0 | $4.24M | 0.66% | +$4.24M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 350,000 | 350,000 | 0 | $3.56M | $3.62M | 0.57% | +$56.0K |
| Soleno Therapeutics Inc | 130,000 | 50,000 | -80,000 | $5.84M | $3.57M | 0.56% | -$2.27M |
| Inozyme Pharma Inc | 3,972,318 | 3,867,710 | -104,608 | $11.00M | $3.52M | 0.55% | -$7.48M |
| Akebia Therapeutics, Inc.(AKBA) | 0 | 1,500,000 | +1,500,000 | $0 | $2.88M | 0.45% | +$2.88M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 250,000 | +250,000 | $0 | $2.75M | 0.43% | +$2.75M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 237,935 | 241,957 | +4,022 | $3.33M | $2.75M | 0.43% | -$584.9K |
| Kymera Therapeutics, Inc.(KYMR) | 40,000 | 100,000 | +60,000 | $1.61M | $2.74M | 0.43% | +$1.13M |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 250,000 | 250,000 | 0 | $2.54M | $2.60M | 0.41% | +$57.5K |
| Geron Corporation(GERN) | 2,250,000 | 1,500,000 | -750,000 | $7.96M | $2.38M | 0.37% | -$5.58M |
| Monopar Therapeutics Inc.(MNPR) | 0 | 62,000 | +62,000 | $0 | $2.26M | 0.35% | +$2.26M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 70,742 | 49,692 | -21,050 | $2.93M | $2.24M | 0.35% | -$686.6K |
| Aerovate Therapeutics Inc | 800,000 | 800,000 | 0 | $2.12M | $2.01M | 0.31% | -$112.0K |
| Cullinan Therapeutics, Inc.(CGEM) | 263,817 | 263,817 | 0 | $3.21M | $2.00M | 0.31% | -$1.22M |
| Climb Bio, Inc.(CLYM) | 500,000 | 1,500,000 | +1,000,000 | $900.0K | $1.83M | 0.29% | +$930.0K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 144,159 | 394,159 | +250,000 | $1.24M | $1.69M | 0.27% | +$455.1K |
| Roivant Sciences Ltd.SHS(ROIV) | 0 | 150,000 | +150,000 | $0 | $1.51M | 0.24% | +$1.51M |
| Nkarta, Inc.(NKTX) | 800,000 | 800,000 | 0 | $1.99M | $1.47M | 0.23% | -$520.0K |
| Anteris Technologies Global Corp.(AVR) | 300,000 | 390,000 | +90,000 | $1.67M | $1.42M | 0.22% | -$254.4K |
| MBX Biosciences, Inc.(MBX) | 0 | 175,000 | +175,000 | $0 | $1.29M | 0.20% | +$1.29M |
| Third Harmonic Bio Inc | 0 | 370,000 | +370,000 | $0 | $1.28M | 0.20% | +$1.28M |
| 89bio Inc | 0 | 175,000 | +175,000 | $0 | $1.27M | 0.20% | +$1.27M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 200,000 | +200,000 | $0 | $1.25M | 0.20% | +$1.25M |
| Olema Oncology, Inc.(OLMA) | 0 | 325,000 | +325,000 | $0 | $1.22M | 0.19% | +$1.22M |
| Nextcure Inc | 2,302,598 | 2,302,598 | 0 | $1.78M | $1.11M | 0.17% | -$669.4K |
| MeiraGTx Holdings plc(MGTX) | 0 | 150,000 | +150,000 | $0 | $1.02M | 0.16% | +$1.02M |
| Vaxcyte, Inc.(PCVX) | 25,000 | 25,000 | 0 | $2.05M | $944.0K | 0.15% | -$1.10M |
| Viking Therapeutics, Inc.(VKTX) | 0 | 25,000 | +25,000 | $0 | $603.8K | 0.09% | +$603.8K |
| Sutro Biopharma, Inc.(STRO) | 0 | 752,722 | +752,722 | $0 | $489.7K | 0.08% | +$489.7K |
| Context Therapeutics Inc.(CNTX) | 1,015,340 | 660,589 | -354,751 | $1.07M | $404.3K | 0.06% | -$661.8K |
| Black Diamond Therapeutics I | 559,163 | 250,000 | -309,163 | $1.20M | $387.5K | 0.06% | -$809.1K |
| Radiopharm Theranostics LimitedADS(RADX) | 156,171 | 64,600 | -91,571 | $684.0K | $310.7K | 0.05% | -$373.3K |
| Zura Bio LimitedCL A(ZURA) | 223,335 | 223,335 | 0 | $558.3K | $288.1K | 0.05% | -$270.2K |
| Compass Therapeutics, Inc.(CMPX) | 0 | 130,807 | +130,807 | $0 | $248.5K | 0.04% | +$248.5K |
| Ovid Therapeutics Inc.(OVID) | 0 | 667,516 | +667,516 | $0 | $208.2K | 0.03% | +$208.2K |
| Repare Therapeutics Inc | 100,000 | 200,000 | +100,000 | $131.0K | $197.2K | 0.03% | +$66.2K |
| Adagio Medical Holdings, Inc.(ADGM) | 213,235 | 213,235 | 0 | $223.9K | $169.5K | 0.03% | -$54.4K |
| Omeros Corporation(OMER) | 9,958 | 9,958 | 0 | $98.4K | $81.9K | 0.01% | -$16.5K |
| Allakos Inc | 0 | 250,000 | +250,000 | $0 | $56.9K | 0.01% | +$56.9K |
| Q32 Bio Inc.(QTTB) | 27,777 | 27,777 | 0 | $95.6K | $45.8K | 0.01% | -$49.7K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 75,000 | 75,000 | 0 | $2.6K | $3.5K | 0.00% | +$952 |
| Immatics N.VW EXP 07 01 202 | 187,204 | 187,204 | 0 | $47.1K | $3.0K | 0.00% | -$44.1K |
| Apellis Pharmaceuticals Inc COM | 50,000 | 0 | -50,000 | $1.60M | $0 | — | -$1.60M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 300,000 | 0 | -300,000 | $5.64M | $0 | — | -$5.64M |
| Arvinas, Inc.(ARVN) | 630,000 | 0 | -630,000 | $12.08M | $0 | — | -$12.08M |
| Celldex Therapeutics, Inc.(CLDX) | 9,992 | 0 | -9,992 | $252.5K | $0 | — | -$252.5K |
| CG Oncology, Inc.(CGON) | 100,000 | 0 | -100,000 | $2.87M | $0 | — | -$2.87M |
| Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS) | 0 | 0 | 0 | $16.19M | $0 | — | -$16.19M |
| COMPASS Pathways plcADS(CMPS) | 850,512 | 0 | -850,512 | $3.21M | $0 | — | -$3.21M |
| Helix Acquisition Corp IiCL A | 250,000 | 0 | -250,000 | $2.63M | $0 | — | -$2.63M |
| Inari Med Inc | 25,000 | 0 | -25,000 | $1.28M | $0 | — | -$1.28M |
| Kezar Life Sciences Inc COM NEW | 142,316 | 0 | -142,316 | $956.4K | $0 | — | -$956.4K |
| Rapt Therapeutics Inc | 1,000,000 | 0 | -1,000,000 | $1.58M | $0 | — | -$1.58M |
| Savara Inc.(SVRA) | 410,586 | 0 | -410,586 | $1.26M | $0 | — | -$1.26M |
| Syros Pharmaceuticals Inc | 150,000 | 0 | -150,000 | $34.5K | $0 | — | -$34.5K |
| Tectonic Therapeutic, Inc.(TECX) | 58,331 | 0 | -58,331 | $2.69M | $0 | — | -$2.69M |